Literature DB >> 25501032

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.

Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Mary S Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon Spector, Karin Rosén.   

Abstract

Entities:  

Year:  2014        PMID: 25501032     DOI: 10.1038/jid.2014.512

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  17 in total

1.  Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.

Authors:  Eric Tyrell Oliver; Kris Chichester; Kelly Devine; Patricia Meghan Sterba; Craig Wegner; Becky Marie Vonakis; Sarbjit Singh Saini
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

Review 2.  Targeting key proximal drivers of type 2 inflammation in disease.

Authors:  Namita A Gandhi; Brandy L Bennett; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

Review 3.  From IgE to Omalizumab.

Authors:  Toshiaki Kawakami; Ulrich Blank
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

Review 4.  Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review.

Authors:  Benjamin Greiner; Savannah Nicks; Michael Adame; Jennifer McCracken
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-01       Impact factor: 10.817

Review 5.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

Review 6.  Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.

Authors:  Christian Vestergaard; Mette Deleuran
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

7.  Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies.

Authors:  Misbah Nasheela Ghazanfar; Simon Francis Thomsen
Journal:  Case Rep Med       Date:  2015-01-29

8.  Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review.

Authors:  Diana C Carrillo; Mario Sanchez Borges; Elizabeth García; Eduardo Egea; Carlos D Serrano
Journal:  World Allergy Organ J       Date:  2014-12-31       Impact factor: 4.084

Review 9.  Profile of omalizumab in the treatment of chronic spontaneous urticaria.

Authors:  Moises Labrador-Horrillo; Marta Ferrer
Journal:  Drug Des Devel Ther       Date:  2015-08-25       Impact factor: 4.162

10.  Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.

Authors:  Luke F Pennington; Svetlana Tarchevskaya; Daniel Brigger; Karthik Sathiyamoorthy; Michelle T Graham; Kari Christine Nadeau; Alexander Eggel; Theodore S Jardetzky
Journal:  Nat Commun       Date:  2016-05-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.